Wendel Barr has become the new CEO of Synteract, a portfolio company of Gryphon Investors since 2008. Mr. Barr was most recently the COO and executive vice president of Covance. Synteract's existing CEO, Ellen Morgan, will continue to serve as chairman of the company's Board. Synteract is a contract research organization serving the biotechnology, medical device and pharmaceutical sectors.
